ClinicalTrials.Veeva

Find clinical trials for Breast Cancer in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Nashville, TN, USA:

Niraparib + Dostarlimab In BRCA Mutated Breast Cancer

This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...

Enrolling
Breast Cancer
Stage II Breast Cancer
Drug: Niraparib
Drug: Dostarlimab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Nashville, Tennessee, United States and 8 other locations

This research study is evaluating how well Breast Cancer responds to preoperative treatment with Endocrine treatment in combination ...

Active, not recruiting
Breast Cancer
Drug: Endocrine Therapy
Drug: Tamoxifen

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Nashville, Tennessee, United States and 10 other locations

This research study is a way of gaining new knowledge about the combination of Taselisib with other drugs in the treatment of metastatic breast...

Active, not recruiting
Metastatic Breast Cancer
Recurrent Breast Cancer
Drug: Paclitaxel
Drug: Trastuzumab emtansine

Phase 1

Otto Metzger, MD

Nashville, Tennessee, United States and 2 other locations

therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:A combi...

Enrolling
Breast Cancer
Hormone Receptor Positive Breast Cancer
Drug: ADJUVANT ENDOCRINE THERAPY
Combination Product: Pertuzumab+TRASTUZUMAB

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Nashville, Tennessee, United States and 25 other locations

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting
Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Nashville, Tennessee, United States and 9 other locations

This is a randomized trial for patients with metastatic hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative breast...

Active, not recruiting
Metastatic Breast Cancer
Breast Carcinoma
Drug: LEE-011
Drug: Fulvestrant

Phase 2

Melissa K Accordino

Nashville, Tennessee, United States and 12 other locations

This trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with ER+/HER2- localized breast cancer...

Active, not recruiting
Breast Cancer
Procedure: Surgical resection of breast tumor
Drug: ARV-471

Phase 2

Arvinas
Arvinas

Nashville, Tennessee, United States and 48 other locations

The purpose of this study is to assess safety and tolerability of AZD2014 when given in combination with Fulvestrant

Active, not recruiting
Advanced Metastatic Breast Cancer
Drug: AZD2014
Drug: Fulvestrant

Phase 1

AstraZeneca
AstraZeneca

Nashville, Tennessee, United States and 4 other locations

to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...

Enrolling
Locally Advanced Breast Cancer
Metastatic Breast Cancer
Drug: U3-1402

Phase 2

Sarah Cannon Research Institute
Sarah Cannon Research Institute

Nashville, Tennessee, United States and 10 other locations

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...

Active, not recruiting
Breast Cancer
Drug: ARV-471 in combination with Everolimus

Phase 1

Arvinas
Arvinas

Nashville, Tennessee, United States and 8 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems